Table 3 Association of a history of Type 2 DM and first event AMI
T2DM (event/N) | Effect | Breslow-Day homogeneity test | |||||
|---|---|---|---|---|---|---|---|
No | Yes | OR | IC95 | ||||
Sex | |||||||
Women | 133/12741 | 228/12644 | 1.741 | 1.397 | 2.175 | 0.426 | 0.636 |
Men | 133/5708 | 228/5805 | 1.613 | 1.276 | 2.047 | 0.380 | |
Age | |||||||
< 65 years | 100/9807 | 144/9719 | 1.460 | 1.121 | 1.906 | 0.315 | 0.176 |
> =65 years | 154/8642 | 280/8730 | 1.826 | 1.491 | 2.243 | 0.452 | |
CKD | |||||||
No | 198/15409 | 330/15415 | 1.681 | 1.402 | 2.015 | 0.405 | 0.944 |
Yes | 56/3040 | 94/3034 | 1.704 | 1.206 | 2.424 | 0.413 | |
Control HTA | |||||||
No | 31/1797 | 48/1747 | 1.609 | 0.998 | 2.629 | 0.585 | 0.385 |
Yes | 223/16652 | 376/16702 | 1.697 | 1.431 | 2.012 | 0.398 | |
Dyslipidemia | |||||||
No | 8/2493 | 19/2466 | 2.412 | 1.006 | 6.379 | 0.464 | 0.647 |
Yes | 246/15956 | 405/15983 | 1.660 | 1.410 | 1.955 | 0.384 | |
Obesity | |||||||
No | 146/9171 | 246/9134 | 1.711 | 1.385 | 2.119 | 0.416 | 0.835 |
Yes | 108/9278 | 178/9315 | 1.654 | 1.293 | 2.124 | 0.395 | |
Hypertension | |||||||
No | 1/534 | 0/514 | 0.2026a | ||||
Yes | 253/17915 | 424/17935 | 1.690 | 1.440 | 1.984 | 0.408 | |
ACEI-ARB | |||||||
No | 22/6374 | 25/6377 | 1.136 | 0.614 | 2.116 | 0.120 | 0.159 |
Yes | 232/12075 | 399/12072 | 1.745 | 1.476 | 2.062 | 0.427 | |
Calcium Antagonist | |||||||
No | 120/12673 | 191/12632 | 1.606 | 1.270 | 2.038 | 0.377 | 0.577 |
Yes | 134/5776 | 233/5817 | 1.757 | 1.410 | 2.196 | 0.431 | |
Statins | |||||||
No | 25/9126 | 55/9067 | 2.222 | 1.359 | 3.723 | 0.550 | 0.223 |
Yes | 229/9323 | 369/9382 | 1.626 | 1.371 | 1.929 | 0.385 | |
Antiplatelet | |||||||
No | 44/11207 | 83/11102 | 1.911 | 1.309 | 2.823 | 0.477 | 0.442 |
Yes | 210/7242 | 341/7347 | 1.630 | 1.363 | 1.949 | 0.386 | |
Number antihypertensive drugs | |||||||
< 2 | 24/9062 | 34/9421 | 1.364 | 0.785 | 2.406 | 0.267 | 0.324 |
> =2 | 230/9387 | 390/9028 | 1.798 | 1.518 | 2.129 | 0.444 | |